Coming Soon
Spravato®
Spravato® (esketamine) is a treatment option for eligible adults with treatment-resistant depression. It is administered in a certified healthcare setting with monitoring after each dose.
This service is not yet available at ClearPath. Availability, eligibility criteria, and scheduling details will be confirmed before the program opens.
Join the Spravato® Interest List
Share your contact information and we'll reach out once the program becomes available.
Joining the interest list does not guarantee that you will qualify for treatment or that your insurance company will approve SPRAVATO®. Every patient must complete an appropriate clinical evaluation before treatment.
Prefer to reach us directly? 346-654-0689 · info@clearpathpsycwellness.com
Process
What Happens Next?
- Step 1
Initial Screening
We review basic eligibility and previous depression treatments.
- Step 2
SPRAVATO® Consultation
An appropriate psychiatric provider completes a comprehensive evaluation and determines whether SPRAVATO® may be appropriate.
- Step 3
Insurance Verification & Prior Authorization
When required, our team submits the necessary clinical documentation to the patient's insurance plan.
- Step 4
Treatment Scheduling
Once eligibility, authorization, and treatment arrangements are completed, treatment sessions can be scheduled.